HKU IP Seminar Series | Repurposing Drugs - Patentability, Enforceability and Freedom to Operate

date 10 November 2026
pin Seminar Room 4, 4/F, 3 Sassoon Road
desc

As part of Xelerator Months 2026 — Navigating Your Journey From Research to Impact — you are invited to the next session of the HKU IP Seminar Series.

Xelerator Months 2026m KV

Organised by the HKUMed Technology Transfer Unit in collaboration with the IP Management and Compliance (IMC) unit of HKU RISE, this seminar sits within the broader Xelerator Months programme, which continues through mid-January.

Repurposing Drugs - Patentability, Enforceability and Freedom to Operate AI-generated content may be incorrect.

This session is particularly relevant for researchers working on medicine-related projects. It covers practical intellectual property considerations when exploring new therapeutic uses for existing compounds, including:

  • Patentability of repurposed indications
  • Enforceability challenges
  • Freedom-to-operate analysis before further development or partnering
Dr. Stanley Ng is an Assistant Director of Intellectual Property Management at HKU, contributing to the RISE initiative by driving IP management, technology transfer, and research commercialization. He is a Hong Kong solicitor with a PhD in Chemistry and a Master's in Intellectual Property Law, specializing in patent strategy, R&D collaborations, technology licensing, and IP protection. AI-generated content may be incorrect.

Whether you are evaluating a new indication, preparing a disclosure, or assessing commercialisation pathways, this session offers a practical next step — including a face-to-face Q&A where you can ask Dr Stanley Ng about your own projects.

Registration Button

Please feel free to circulate this to interested members of your research team. We look forward to seeing you there.